Stephen Moore
Family Medicine · Tucson, AZNPI 1326087008
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $567 and has fallen 96.4% since, to $20 in 2025.
Across 94 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$280
- Abbott$136
- AbbVie$119
- Merck$119
- Amgen$115
- Novo Nordisk$68
- plus $665 from 22 others
What the payments were for
- Food & beverage$1,496100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $280 |
| Abbott | 7 | $136 |
| AbbVie | 7 | $119 |
| Merck | 9 | $119 |
| Amgen | 6 | $115 |
| Novo Nordisk | 5 | $68 |
| GSK | 5 | $64 |
| Boehringer Ingelheim | 4 | $57 |
| Lilly USA, LLC | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 3 | $46 |
| Pfizer | 3 | $42 |
| Gilead | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Amarin Pharma, Inc. | 3 | $36 |
| Protega Pharmaceutials Inc | 1 | $35 |
| Radius Health, Inc. | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Scilex Pharmaceuticals Inc. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $13 |
| Phadia US Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Astellas Pharma US Inc | 1 | $11 |
How this compares
$1,502 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 26 | $753 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $545 |
| Ezetimibe | 23 | $524 |
| Levothyroxine Sodium | 45 | $454 |
| Atorvastatin Calcium | 40 | $414 |
| Rosuvastatin Calcium | 38 | $372 |
| Pantoprazole Sodium | 28 | $369 |
| Losartan Potassium | 36 | $340 |
| Omeprazole | 18 | $319 |
| Amlodipine Besylate | 33 | $285 |
| Celecoxib | 13 | $271 |
| Montelukast Sodium | 14 | $171 |
| Lisinopril | 21 | $142 |
| Metformin Hcl | 17 | $107 |
| Zolpidem Tartrate | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tucson
- Katherine WilsonTucson$29K
- Kimy CharaniTucson$21K
- Mark GrantTucson$21K
- Christian MoherTucson$13K
- Dean WrightTucson$12K
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.